New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 29, 2022 - The FDA approved Therakind’s Jylamvo (methotrexate) oral solution.
Download PDF
Return to publications
